Treatment
Drug clinical trials
We’re tracking 1,296 recruiting studies that include Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT06910605Recruiting
Driving simulator study for ADHD patients on drug holidays
This study uses a driving simulator to see how ADHD patients’ driving changes when they take a break from their stimulant medication (drug holiday). It may help explain how medication affects driving performance.
Zurich, ZRHAges 10 years+ - NCT06922669Recruiting
Steroids for drug-induced liver injury with high bilirubin
This trial tests whether steroids (glucocorticoids) can help people with acute liver injury caused by a drug, especially when bilirubin levels are high. It aims to see if steroids can reduce liver damage and improve recovery.
Shenyang, LiaoningAges 18–80 - NCT06922786Recruiting
Blood filter to remove drugs in overdoses
This trial tests a blood-filtering device (hemadsorption) to help remove drugs from the body faster in people who are in the ICU after an overdose of certain sedatives or antidepressants, especially if they have liver or kidney problems.
Brussels, Brussels CapitalAges 18 years+ - NCT06928259Recruiting
A study of hepatitis C treatments and other medications
This trial looks at how two hepatitis C treatments (GLE/PIB or SOF/VEL) interact with other drugs or recreational substances. It may help doctors understand how to better manage treatment for people taking multiple medications.
CadizAges Any age - NCT06951854RecruitingPhase 2
Testing a new drug for children with autism
This trial tests a new medicine (NV01-A02) in children aged 6 to 15 who have autism. The goal is to see if the drug is safe and helpful for managing autism symptoms.
Seoul, SeoulAges 6–15 - NCT06967831Recruiting
Testing existing drugs for mitochondrial disorders
This trial looks at whether drugs already approved for other conditions might help people with Leigh syndrome, a rare mitochondrial disorder. Researchers will study cells made from your skin to see how these drugs work.
Düsseldorf, North Rhine-WestphaliaAges Any age - NCT07010445Recruiting
Gut-brain connection in resistant epilepsy
This study looks at how the gut and brain talk to each other in people with epilepsy, especially when seizures are hard to control. It may help find new ways to treat epilepsy by focusing on the gut.
Milan, LombardyAges 3–50 - NCT07037732Recruiting
Monitoring rituximab in autoimmune diseases
This study looks at the levels of rituximab (a medicine that calms the immune system) and your body's response to it in people with certain autoimmune diseases. It may help doctors understand how to better adjust treatment.
Nice, Alpes MaritimesAges 18 years+ - NCT07064343Recruiting
Anti-drug adventure program for young students
This study tests an adventure-based program to help prevent drug use among college students. Participants take part in outdoor activities designed to build resilience and avoid substance abuse.
Hong KongAges 18–35 - NCT07077473Recruiting
Comparing FMF treatments used in daily care
This study looks at how well and safely different real-world treatments work for people with Familial Mediterranean Fever (FMF). It aims to find which medicines help best for this inherited inflammatory disorder.
Wuhan, HubeiAges Any age - NCT07122167Recruiting
Study of a drug-coated stent for blocked leg arteries
This study is testing a new drug-coated stent for blocked arteries in the thigh or behind the knee. It may help people with moderate to severe leg pain or wounds by improving blood flow without needing surgery.
Chrzanów, ChrzanowAges 18–80 - NCT07128888RecruitingPhase 1
GZR18 injection effects on stomach emptying and drug interactions
This trial tests how a new injectable drug, GZR18, affects how fast your stomach empties and how it interacts with other medicines. It is for obese Chinese adults who want to join a research study.
BeijingAges 18–50 - NCT07138144RecruitingPhase 4
Switching to a two-drug HIV pill vs. staying on three drugs
This study tests whether switching to a simpler, two-drug HIV pill (dolutegravir/lamivudine) is as safe and effective as staying on a three-drug regimen. It is for people whose HIV is already well-controlled and who are currently taking Biktarvy or Triumeq.
Mexico City, Mexico CityAges 18–70 - NCT07164950Recruiting
Compression stockings to prevent nerve damage from ADC therapy
This trial tests whether wearing compression stockings can help prevent nerve damage (peripheral neuropathy) caused by a type of chemotherapy called antibody-drug conjugate (ADC) in people with advanced cancers like bladder cancer. If you are starting treatment with an ADC and don't have existing nerve problems, you may be able to join.
ShanghaiAges 18–75 - NCT07171554Recruiting
A test to find the best drugs for advanced colorectal cancer
This trial uses a special test to help choose which drugs might work best for you if you have metastatic colorectal cancer that has stopped responding to first treatment. The goal is to match you with a more effective next therapy.
Lørenskog, AkershusAges 18 years+ - NCT07176208RecruitingPhase 1
THC and alcohol effects on driving in healthy adults
This study looks at how taking THC (the active ingredient in cannabis) with or without alcohol affects your driving and perception. You will take a THC pill and possibly a drink with alcohol, then have your driving tested in a simulator.
West Bend, WisconsinAges 21–55 - NCT07199335RecruitingPhase 4
Injectable HIV prevention drug for people who inject drugs
This study tests a long-acting injectable medication called cabotegravir to prevent HIV in people who inject drugs. If you have injected street drugs recently, you may be able to get this shot every few months instead of taking daily pills.
Boston, MassachusettsAges 18 years+ - NCT07203352RecruitingPhase 3
Targeted drugs plus chemo for T-cell acute lymphoblastic leukemia
This trial tests whether adding targeted drugs to standard chemotherapy works better for adults newly diagnosed with T-ALL. If you have not had any prior treatment for leukemia, this study might be an option.
Guangzhou, GuangdongAges 18–70 - NCT07216846Recruiting
Preventing medication harm in older adults after a fall
This trial tests a program for older adults (65+) who have had a fall at ground level. It aims to reduce harm from medications by using special care in the emergency department.
Delray Beach, FloridaAges 65–110 - NCT07229248RecruitingPhase 3
Balloon vs. Stent in Young Heart Attack Patients
This trial compares a drug-coated balloon (DCB) to a drug-eluting stent (DES) in younger adults having their first major heart attack. The goal is to see which treatment works better when the artery is opened quickly.
KarachiAges 18–49 - NCT07230847Recruiting
Healing of drug-coated vs. standard stents in high-bleeding-risk patients
This trial compares two types of stents (a drug-coated stent and a standard drug-eluting stent) in people with acute coronary syndrome who also have a high risk of bleeding. It uses a special camera to look at how the artery heals one month after the stent is placed.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07231835Recruiting
Coronary outcomes with drug-coated balloon treatment
This study tracks patients who receive a special balloon coated with medicine (paclitaxel) to open blocked heart arteries. It aims to understand how well this treatment works for various types of blockages.
AmsterdamAges 18 years+ - NCT07248826Recruiting
Developing guidelines for herb-drug interactions in Chinese medicine
This trial is creating a set of rules (a framework) to help doctors and patients understand how Chinese herbs might interact with prescription drugs. It is looking for healthcare professionals and decision-makers who work with both Chinese and Western medicine to help develop these guidelines.
Hong Kong, Hong KongAges 18 years+ - NCT07251153RecruitingPhase 1
Comparing two forms of vonafexor in healthy volunteers
This study compares two forms of an experimental drug called vonafexor to see how they work in the body and if they interact with other medications. It's for healthy volunteers to make sure the drug is safe before testing in patients with liver disease.
GièresAges 18–65
Common questions
- Are there clinical trials studying Drug?
- Yes. Clin2 currently lists 1,296 recruiting studies that include Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.